Suppr超能文献

孕期催乳素分泌性腺瘤的管理

Managing prolactin-secreting adenomas during pregnancy.

作者信息

Imran Syed Ali, Ur Ehud, Clarke David B

机构信息

Division of Endocrinology and Metabolism, Dalhousie University, Halifax, NS B3H 2Y9.

出版信息

Can Fam Physician. 2007 Apr;53(4):653-8.

Abstract

OBJECTIVE

To determine an appropriate approach to managing prolactin-secreting adenomas of varying severity in pregnant women.

SOURCES OF INFORMATION

MEDLINE was searched using the key words "hyperprolactinemia," "prolactinoma," "pregnancy," and "management." Experience from a multidisciplinary tertiary care centre was also reviewed. Recommendations are based on mostly levels II and III evidence.

MAIN MESSAGE

With appropriate management, most women with hyperprolactinemia can achieve pregnancy. Although most women with prolactin-secreting adenomas during pregnancy need only careful observation, others might require medical treatment or even surgical evacuation. Ideally, such patients should be managed by multidisciplinary teams. In the absence of such teams, most pregnant women with small tumours can be managed safely by their primary physicians. Those with large tumours should be referred to specialists.

CONCLUSION

Family physicians play an important role in managing women with prolactinomas during pregnancy. Knowledge of current approaches to management is crucial in determining when and how to refer these patients.

摘要

目的

确定一种合适的方法来管理孕期不同严重程度的泌乳素分泌型腺瘤。

信息来源

使用关键词“高泌乳素血症”“泌乳素瘤”“妊娠”和“管理”检索MEDLINE。还回顾了一个多学科三级护理中心的经验。建议主要基于二级和三级证据。

主要信息

通过适当管理,大多数高泌乳素血症女性能够怀孕。虽然大多数孕期患有泌乳素分泌型腺瘤的女性仅需密切观察,但其他女性可能需要药物治疗甚至手术切除。理想情况下,此类患者应由多学科团队管理。若没有这样的团队,大多数小肿瘤的孕妇可由其初级医生安全管理。大肿瘤患者应转诊给专科医生。

结论

家庭医生在管理孕期患有泌乳素瘤的女性中发挥着重要作用。了解当前的管理方法对于确定何时以及如何转诊这些患者至关重要。

相似文献

1
Managing prolactin-secreting adenomas during pregnancy.
Can Fam Physician. 2007 Apr;53(4):653-8.
2
Management of prolactinomas during pregnancy.
Minerva Endocrinol. 2013 Dec;38(4):351-63.
3
Diagnosis and treatment of prolactinomas.
Adv Intern Med. 1999;44:117-53.
4
Pregnancy and Tumor Outcomes in Women with Prolactinoma.
Exp Clin Endocrinol Diabetes. 2017 Nov;125(10):642-648. doi: 10.1055/s-0043-112861. Epub 2017 Jul 13.
5
Medical management of prolactin-secreting pituitary adenomas.
Pituitary. 2002;5(2):55-65. doi: 10.1023/a:1022375429083.
6
Clinical practice. Prolactinomas.
N Engl J Med. 2010 Apr 1;362(13):1219-26. doi: 10.1056/NEJMcp0912025.
7
Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
Hormones (Athens). 2019 Jun;18(2):137-139. doi: 10.1007/s42000-018-0071-z. Epub 2018 Oct 19.
8
[Prolactinoma and pregnancy].
Akush Ginekol (Sofiia). 2004;43 Suppl 2:16-22.
9
[Bromocriptine therapy of prolactinoma in pregnancy].
Zentralbl Gynakol. 1985;107(14):899-903.
10
[Prolactin--a hormone with many effects].
Lakartidningen. 1999 Mar 10;96(10):1171-4.

引用本文的文献

2
Managing Prolactinomas during Pregnancy.
Front Endocrinol (Lausanne). 2015 May 26;6:85. doi: 10.3389/fendo.2015.00085. eCollection 2015.
3
Management of prolactinomas in Brazil: an electronic survey.
Pituitary. 2010 Sep;13(3):199-206. doi: 10.1007/s11102-010-0217-8.
4
Postpartum cardiomyopathy: a cardiac emergency for gynecologists, general practitioners, internists, pulmonologists, and cardiologists.
Dtsch Arztebl Int. 2008 Oct;105(44):751-6. doi: 10.3238/arztebl.2008.0751. Epub 2008 Oct 31.

本文引用的文献

1
Prolactinomas and pregnancy.
Pituitary. 2005;8(1):31-8. doi: 10.1007/s11102-005-5083-4.
2
Clinical practice. Prolactinoma.
N Engl J Med. 2003 Nov 20;349(21):2035-41. doi: 10.1056/NEJMcp025334.
3
Pituitary tumors and pregnancy.
Growth Horm IGF Res. 2003 Aug;13 Suppl A:S38-44. doi: 10.1016/s1096-6374(03)00054-6.
5
Management of prolactinomas during pregnancy.
J Reprod Med. 1999 Dec;44(12 Suppl):1121-6.
6
Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment.
Acta Radiol. 1998 Jan;39(1):64-9. doi: 10.1080/02841859809172152.
7
Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy.
Eur J Endocrinol. 1996 Oct;135(4):413-20. doi: 10.1530/eje.0.1350413.
8
Pregnancy outcome after treatment with the ergot derivative, cabergoline.
Reprod Toxicol. 1996 Jul-Aug;10(4):333-7. doi: 10.1016/0890-6238(96)00063-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验